Journal article
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy
British Journal of Clinical Pharmacology, Vol.86(9), pp.1778-1789
2020
Abstract
Immune checkpoint inhibitors have emerged as a revolutionary treatment option for patients with various types of malignancy. Although these agents afford a significant improvement in outcomes for melanoma and other previously untreatable malignancies, their novel mechanism of action may predispose patients to immune‐related adverse effects (irAEs). In the tumour neoantigen environment, these irAEs are due to the activation of the immune system by the blockade of suppressive checkpoints, leading to increases in T‐cell activation and proliferation. IrAEs have been reported in almost any organ and at any point in time, even months to years after discontinuation of therapy. Certain populations with distinct physiological changes, genetic risk factors, and specific antigen exposures may be more highly predisposed to develop irAEs. This review discusses the incidence and mechanisms of irAEs and the relationship between host factors and irAE occurrence.
Details
- Title
- Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy
- Authors/Creators
- B.L. Mangan (Author/Creator) - Vanderbilt University Medical CenterR.K. McAlister (Author/Creator) - Vanderbilt University Medical CenterJ.M. Balko (Author/Creator) - Vanderbilt University Medical CenterD.B. Johnson (Author/Creator) - Vanderbilt University Medical CenterJ.J. Moslehi (Author/Creator) - Vanderbilt University Medical CenterA. Gibson (Author/Creator) - Murdoch UniversityE.J. Phillips (Author/Creator) - Vanderbilt University Medical Center
- Publication Details
- British Journal of Clinical Pharmacology, Vol.86(9), pp.1778-1789
- Publisher
- Wiley
- Identifiers
- 991005541362807891
- Copyright
- © 2020 The British Pharmacological Society
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
36 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.6 Immunology
- 1.6.214 Checkpoint Inhibition
- Web Of Science research areas
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology